1. Metabolic Enzyme/Protease MAPK/ERK Pathway GPCR/G Protein TGF-beta/Smad Apoptosis
  2. Farnesyl Transferase Ras TGF-β Receptor Apoptosis
  3. L-744832

L-744832 is a farnesyl transferase inhibitor. L-744832 effectively inhibits the farnesylation of H-Ras and N-Ras, but has little effect on K-Ras treatment. L-744832 not only directly targets the oncogenic pathway by inhibiting Ras farnesylation, but also enhances radiosensitivity by restoring TGF-β signaling through epigenetic reprogramming. L-744832 can induce cell cycle arrest and apoptosis. L-744832 can be used in combination therapy studies for Ras-driven tumors such as pancreatic cancer.

For research use only. We do not sell to patients.

L-744832

L-744832 Chemical Structure

CAS No. : 160141-09-3

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All Ras Isoform Specific Products:

View All TGF-β Receptor Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

L-744832 is a farnesyl transferase inhibitor. L-744832 effectively inhibits the farnesylation of H-Ras and N-Ras, but has little effect on K-Ras treatment. L-744832 not only directly targets the oncogenic pathway by inhibiting Ras farnesylation, but also enhances radiosensitivity by restoring TGF-β signaling through epigenetic reprogramming. L-744832 can induce cell cycle arrest and apoptosis. L-744832 can be used in combination therapy studies for Ras-driven tumors such as pancreatic cancer[1][2].

In Vitro

L-744832 (0.1-50 μM, 24-72 h) shows significant differences in sensitivity in Panc-1, Capan-2, BxPC-3, AsPC-1 and CFPAC-1 cells with IC50s of 1.3, 2.1, 12.3, 14.3 and > 50 μM[1].
L-744832 (0.1-50 μM, 72 h) arrest the sensitive cell lines (Panc-1, Capan-2, BxPC-3 and AsPC-1) in the G2/M phase of the cell cycle and the arrest occurs during the mitotic entry stage downstream of the G2/M checkpoint[1].
L-744832 (10 μM, 24-72 h) induces above five types of cell apoptosis, and the combination of radiotherapy can significantly increase the apoptosis rate of MIA PaCa-2 cells, while this effect is not observed in BxPC-3 cells[1][2].
L-744832 (0.1-10 μM) with ionizing radiation results in enhanced cytotoxicity in human pancreatic cancer cells[1].
L-744832 (5-10 μM) effectively inhibits the farnesylation of H-Ras and N-Ras and MIA PaCa-2 cells are more sensitive than BxPC-3 cells[2].
L-744832 (5-10 μM, 3-6 h) restores the expression of TGF-β type II receptor (RII) through regulating DNMT1, thereby re-establishing the tumor-suppressing function of TGF-β[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cycle Analysis[2]

Cell Line: Panc-1, Capan-2, BxPC-3, AsPC-1 and CFPAC-1 cells
Concentration: 0.1, 0.5, 1, 10, 25 and 50 μM
Incubation Time: 72 h
Result: Dose-dependent increased in G2/M phase accumulation and the proportion of G2/M phase cells in Panc-1 cells increased nearly threefold.

Apoptosis Analysis[2]

Cell Line: Panc-1, Capan-2, BxPC-3, AsPC-1 and CFPAC-1 cells
Concentration: 10 μM
Incubation Time: 72 h
Result: Showed chromatin condensation and nuclear fragmentation.
Increased the apoptotic index in each group, and this occurred in both wild-type p53 (Capan-2) cells and mutant p53 (Panc-1) cells.

Western Blot Analysis[2]

Cell Line: Panc-1, Capan-2, BxPC-3, AsPC-1 and CFPAC-1 cells
Concentration: 10 μM
Incubation Time: 72 h
Result: Significantly increased the activity of Cyclin B1/Cdc2 kinase.

RT-PCR[1]

Cell Line: MIA PaCa-2 cells
Concentration: 10 μM
Incubation Time: 3 and 6 h
Result: Activated the RII promoter to increase its mRNA levels.
Reduced the mRNA levels of DNMT1.

Western Blot Analysis[1]

Cell Line: MIA PaCa-2 cells
Concentration: 10 μM
Incubation Time: 3 and 6 h
Result: Activated the RII promoter to increase its protein levels.
Reduced the protein levels of DNMT1.
Molecular Weight

559.78

Formula

C26H45N3O6S2

CAS No.
SMILES

O=C(OC(C)C)[C@@H](NC([C@@H](OC[C@@H](NC[C@@H](N)CS)[C@@H](C)CC)CC1=CC=CC=C1)=O)CCS(=O)(C)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
L-744832
Cat. No.:
HY-116428
Quantity:
MCE Japan Authorized Agent: